Ceva Biomune Kicks Off $7 Million R&D Facility Renovation
Redevelopment marks second major investment in two years
Kansas Governor Sam Brownback and Lenexa, Kansas Mayor Mike Boehm were on hand at the official kickoff of Ceva Biomune's $7 million R&D facility renovation. Pictured from left to right: Ceva Holdings, Inc. Chief Executive Officer Craig Wallace; Kansas Governor Sam Brownback; Ceva Biomune Chief Executive Officer Daryl Pint; Lenexa, Kansas Mayor Mike Boehm and Vice President, Global Biology Research & Development, Steve Chu.
July 24, 2012 -- Lenexa, Kan. -- Ceva Biomune, a world leader in animal health vaccines, has kicked off the renovation of its R&D facility. A renovation kickoff event was held Friday, July 20 at the Ceva Biomune campus at 8930 Rosehill Road. Attending the event were Kansas Governor Sam Brownback; Lenexa, Kansas Mayor Mike Boehm; Ceva Holdings, Inc. Chief Executive Officer Craig Wallace; Ceva Biomune Chief Executive Officer Daryl Pint; and Vice President, Global Biology Research & Development, Steve Chu.
Currently, R&D operates out of 2,200 square feet of lab space. The renovation will give the team 18,000 square feet of BSL-2 (bio safety level 2) laboratory space and 15,000 square feet of office space. Thirty of Ceva's R&D professionals will work out of leased space in the Venture Accelerator on the Kansas Bioscience Park campus for the one-year duration of the renovation. CRB Contracting was awarded the design-build project.
Ceva Biomune officials signing the ceremonial first beam at the Lenexa, Kansas site of Ceva Biomune's $7 million R&D renovation.
Ceva operates in nearly 150,000 square feet of office, production, research and development, and warehouse space on a campus of six buildings at its U.S. headquarters in Lenexa, Kan. In May 2011, Ceva completed an $18 million expansion of its Biomune poultry vaccine production plant on the same campus. With about 230 employees, the fast growing company added 50 new positions in the last 18 months and anticipates adding between 25 – 100 in the next 18 months.
"This renovation marks the second major investment in our Kansas City operations in two years. We are very pleased with the support of government officials, the great talent pool, and the resources that make this an excellent place to continue to grow our presence in Kansas City's Animal Health Corridor," said Daryl Pint, Chief Executive Officer of Ceva Biomune.
About Ceva Biomune
Ceva Biomune is part of animal health company Ceva Santé Animale and operates the global veterinary health organization's U.S. headquarters from its Lenexa, Kan., campus. In 2005, Ceva Santé Animal entered the area with the 2005 purchase of Biomune Labs.
About Ceva Santé Animale
Ceva's parent company is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry. Its headquarters is in Libourne, France. Visit www.ceva.com.
Lea-Ann Germinder, APR Fellow PRSA
Germinder & Associates, Inc.